Astrana Health Inc. (ASTH)
NASDAQ:ASTH
Want to see ASTH full AI Analyst Report?
ASTH Stock Chart & Stats
$18.59
$0.06(0.19%)
At close: 4:00 PM EST
$18.59
$0.06(0.19%)
Day’s Range― - ―
52-Week Range$18.08 - $39.93
Previous CloseN/A
Volume92.25K
Average Volume (3M)486.40K
Market Cap
$1.83B
Enterprise Value$2.45B
Total Cash (Recent Filing)$478.38M
Total Debt (Recent Filing)$1.07B
Price to Earnings (P/E)59.6
Beta1.11
Next Earnings
Aug 12, 2026EPS Estimate
0.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.62
Shares Outstanding49,583,420
10 Day Avg. Volume392,078
30 Day Avg. Volume486,401
Financial Highlights & Ratios
PEG Ratio-1.09
Price to Book (P/B)1.56
Price to Sales (P/S)0.38
P/FCF Ratio11.65
Enterprise Value/Market Cap1.34
Enterprise Value/Revenue0.70
Enterprise Value/Gross Profit7.47
Enterprise Value/Ebitda16.47
Forecast
1Y Price Target
$44.50Price Target Upside139.38% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
EPS Forecast (FY)1.27
Revenue Forecast (FY)$4.00B
Bulls Say, Bears Say
Bulls Say
Free Cash Flow GenerationSustained, high free cash flow and strong FCF growth provide durable financial flexibility to fund integrations, invest in AI/automation, return capital or absorb temporary underwriting volatility. FCF roughly matches net income (FCF/NI ~0.95), underscoring cash quality and self‑funding capacity.
Improving Leverage & Balance SheetMaterial deleveraging and a lower debt base materially reduce financial risk and interest burdens, increasing strategic optionality for M&A, investment in platform capabilities, and resilience during enrollment cycles. A stronger balance sheet supports execution of full‑risk rollouts and synergy capture.
Scalable Value‑Based PlatformA large, growing membership and high share of delegated full‑risk arrangements align incentives with payers and providers, enabling durable revenue streams. Measured AI/automation gains (gap closure, AWV completion) indicate scalable operational leverage that should improve margins as cohorts mature.
Bears Say
Compressed Margins & Low ReturnsMargins and returns have deteriorated materially versus prior years, limiting internal capital for growth and reducing earnings resilience. Low net margin and ROE mean even solid revenue growth translates into limited incremental equity returns until medical cost performance and cohort maturation sustainably improve.
Regulatory & Enrollment UncertaintyDependence on public program enrollment and unsettled HQAF/timing creates structural revenue and risk‑adjustment uncertainty. Changes to MA/risk frameworks or material ACA/Medicaid churn could permanently alter realizable capitation economics and the pace at which full‑risk cohorts ramp to target margins.
Clinical Leadership Transition RiskDeparture of the CMO removes a key clinical leader overseeing quality, risk adjustment and provider engagement during a critical period of full‑risk expansion and integration. A prolonged or weak replacement could impair clinical governance, payer/provider relationships and the speed of clinical program maturation.
Astrana Health News
ASTH FAQ
What was Astrana Health Inc.’s price range in the past 12 months?
Astrana Health Inc. lowest stock price was $18.08 and its highest was $39.93 in the past 12 months.
What is Astrana Health Inc.’s market cap?
Astrana Health Inc.’s market cap is $1.83B.
When is Astrana Health Inc.’s upcoming earnings report date?
Astrana Health Inc.’s upcoming earnings report date is Aug 12, 2026 which is in 70 days.
How were Astrana Health Inc.’s earnings last quarter?
Astrana Health Inc. released its earnings results on May 07, 2026. The company reported $0.29 earnings per share for the quarter, missing the consensus estimate of $0.299 by -$0.009.
Is Astrana Health Inc. overvalued?
According to Wall Street analysts Astrana Health Inc.’s price is currently Undervalued.
Does Astrana Health Inc. pay dividends?
Astrana Health Inc. does not currently pay dividends.
What is Astrana Health Inc.’s EPS estimate?
Astrana Health Inc.’s EPS estimate is 0.34.
How many shares outstanding does Astrana Health Inc. have?
Astrana Health Inc. has 49,583,420 shares outstanding.
What happened to Astrana Health Inc.’s price movement after its last earnings report?
Astrana Health Inc. reported an EPS of $0.29 in its last earnings report, missing expectations of $0.299. Following the earnings report the stock price went up 8.925%.
Which hedge fund is a major shareholder of Astrana Health Inc.?
Currently, no hedge funds are holding shares in ASTH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Astrana Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$44.50 (139.38% Upside)
$44.50 (139.38% Upside)
Blogger Sentiment
Bullish
ASTH Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 224.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 22.0%
Last 30 Days ▲ 16.3%
Last 30 Days ▲ 16.3%
Technicals
SMA
Positive
20 days / 200 days
Momentum
50.65%
12-Months-Change
Fundamentals
Return on Equity
3.88%
Trailing 12-Months
Asset Growth
77.19%
Trailing 12-Months
Company Description
Astrana Health Inc.
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.
ASTH Company Deck
ASTH Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a strong operational and financial quarter with outsized revenue and EBITDA growth, meaningful free cash flow, accelerated deleveraging, confirmed platform‑driven operating leverage from AI, and on‑track integration of the Prospect acquisition. Management remains deliberately conservative in full‑year guidance due to enrollment and HQAF timing uncertainties and highlighted working capital effects from full‑risk transitions. Overall, the positives (robust growth, margin expansion levers, rapid deleveraging, and platform advantages) outweigh the manageable execution and macro/regulatory uncertainties called out by management.View all ASTH earnings summariesASTH Stock 12 Month Forecast
Average Price Target
$44.50
▲(139.38% Upside)
Technical Analysis
Healthcare Services
―
Pediatrix Medical Group
―
Select Medical
―
US Physical Therapy
―
Aveanna Healthcare Holdings
―
Ownership Overview
36.11% Insiders
16.75% Mutual Funds
12.41% Other Institutional Investors
12.64% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---